MIR600HG

Across TCGA pan-cancer cohorts, MIR600HG RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated MIR600HG data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher MIR600HG RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MIR600HG expression acts as an unfavorable survival marker, although some lineages such as HNSC and PAAD show a favorable association.

HNSC, PAAD, and ACC are the cancer types where MIR600HG RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	0.815	0.640	<.001	94	view →
PAAD	DFS	Tertile	All	0.394	0.131	<.001	63	view →
ACC	DFS	Quartile	All	0.262	0.809	<.001	58	view →
LIHC	OS	Median	II,III,IV	0.544	0.804	<.001	43	view →
LUAD	OS	Tertile	All	0.850	0.691	.002	24	view →
OV	OS	Median	All	0.260	0.394	<.001	22	view →
KIRP	DFS	Median	All	0.978	0.785	.004	22	view →
COAD	OS	Quartile	All	0.689	0.902	.002	22	view →
PRAD	DFS	Tertile	All	0.832	0.939	.001	18	view →
UCEC	DFS	Median	IV	0.679	0.241	.006	12	view →
KIRC	OS	Tertile	All	0.870	0.790	.015	10	view →
CHOL	DFS	Quartile	All	0.594	0.115	.041	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

MIR600HG–HNSC (DFS)

Open the HNSC breakdown →